# Maxcyte, Inc.: Form DEF 14A, filed May 26, 2022

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: DEF 14A
- Filed: 2022-05-26
- Accepted by EDGAR: May 26, 2022, 16:35 ET
- Period: 2022-06-29
- Accession: 0001140361-22-020805
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000114036122020805/ny20004287x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000114036122020805/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000114036122020805/ny20004287x1_def14a.htm

Filed May 26, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-020805. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.